| 13 Feb, 11:35 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 13 Feb, 11:33 pm | — | … | Lupin Limited has informed the Exchange about Link of Audio recording of the Earnings Call-Q3 FY26. | nse |
| 13 Feb, 07:52 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 13 Feb, 07:50 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Anand Kripalu Joins Lupin Board as Independent Director ". | nse |
| 12 Feb, 10:49 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 12 Feb, 10:46 pm | — | … | Lupin Limited has informed the Exchange about Investor Presentation on the Unaudited Financial Results for the quarter and nine months ended on December 31, 2025. | nse |
| 12 Feb, 10:42 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 12 Feb, 10:39 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated February 12, 2026, titled "Lupin Q3 FY2026 Results". | nse |
| 12 Feb, 09:25 pm | — | … | Lupin Ltd - 500257 - Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025. | bse |
| 12 Feb, 09:19 pm | — | … | Lupin Limited has submitted to the Exchange, the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2025. | nse |
| 10 Feb, 05:07 pm | — | … | Lupin Limited has informed the Exchange about Schedule of Analyst/Institutional Investors Meet. | nse |
| 10 Feb, 07:38 am | — | … | Lupin Limited has informed the Exchange about a Settlement and License Agreement. | nse |
| 09 Feb, 11:01 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 09 Feb, 10:54 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated February 09, 2026, titled "Made in India The story of Desh Bandhu Gupta, Lupin and Indian Pharma Book Launched in Mumbai". | nse |
| 04 Feb, 08:46 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated February 04, 2026, titled "Lupin Launches Topiramate Extended-Release Capsules in the United States ". | nse |
| 04 Feb, 08:43 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 02 Feb, 11:13 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 02 Feb, 11:02 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated February 02, 2026, titled "Lupin Launches Dasatinib Tablets in the United States". | nse |
| 02 Feb, 10:11 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 02 Feb, 10:08 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated February 02, 2026, titled "Lupin and TB Alliance Join Forces to Advance Telacebec for the Treatment of Tuberculosis and Other Mycobacterial Diseases". | nse |
| 28 Jan, 05:21 pm | — | … | Lupin Limited has informed the Exchange about Schedule of Earnings Call for Unaudited Financial Results of Q3 FY26. | nse |
| 28 Jan, 04:27 pm | — | … | Lupin Ltd - 500257 - Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025. | bse |
| 23 Jan, 12:30 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated January 23, 2026, titled "Lupin Receives Highest ESG Rating from CDP for Climate Change and Water Security." | nse |
| 23 Jan, 12:26 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 21 Jan, 07:52 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 21 Jan, 07:51 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated January 21, 2026, titled Lupin and Galenicum Sign License and Supply Agreement for Semaglutide in 23 Countries. | nse |
| 19 Jan, 04:21 pm | — | … | Lupin Limited has informed the Exchange about ESG Rating by ESG Risk Assessments and Insights Limited. | nse |
| 06 Jan, 09:10 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 06 Jan, 09:07 pm | — | … | Lupin Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 30 Dec, 04:29 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 30 Dec, 04:28 pm | — | … | Lupin Limited has informed the Exchange about an update on acquisition of VISUfarma B.V., the Netherlands. | nse |
| 29 Dec, 06:26 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 29 Dec, 06:25 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated December 29, 2025, titled "Lupin Signs Exclusive Licensing Agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonist". | nse |
| 18 Dec, 03:50 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 18 Dec, 03:41 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated December 18, 2025, titled "Lupin Signs Exclusive Licensing Agreement with Neopharmed for GastroenterologyBrand Plasil® in the Philippines and Brazil". | nse |
| 17 Dec, 11:53 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 17 Dec, 11:48 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated December 17, 2025, titled "Lupin Receives Positive CHMP Opinion for Biosimilar Ranibizumab". | nse |
| 16 Dec, 08:58 pm | — | … | Lupin Limited has informed the Exchange regarding the receipt of Establishment Inspection Report (EIR) by the Company from the U.S. FDA for its injectables facility in Nagpur, India, vide Press Release dated December 16, 2025. | nse |
| 16 Dec, 08:51 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 16 Dec, 10:03 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated December 16, 2025, titled "Lupin Secures SBTi Validation for Emission Reduction Targets". | nse |
| 16 Dec, 10:01 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 12 Dec, 11:47 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 12 Dec, 11:44 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated December 12, 2025, titled "Lupin Manufacturing Solutions and PolyPeptide Announce Strategic Alliance to ScaleGlobal Peptide Supply Chain". | nse |
| 09 Dec, 05:57 pm | — | … | Lupin Limited has informed the Exchange about ESG Rating by NSE Sustainability Ratings & Analytics Limited. | nse |
| 05 Dec, 09:32 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 05 Dec, 09:25 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated December 05, 2025, titled "Lupin Receives Tentative Approval from U.S. FDA for Siponimod Tablets". | nse |
| 04 Dec, 01:22 pm | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 04 Dec, 01:17 pm | — | … | Lupin Limited has informed the Exchange regarding a press release dated December 04, 2025, titled "Lupin and Valorum Enter into an Exclusive Licensing Agreement for Biosimilar Armlupeg (Pegfilgrastim-unne) in the United States". | nse |
| 01 Dec, 07:44 am | — | … | Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) | bse |
| 01 Dec, 07:34 am | — | … | Lupin Limited has informed the Exchange regarding a press release dated December 01, 2025, titled "Lupin Receives Approval from U.S. FDA for Biosimilar Armlupeg (Pegfilgrastim-unne)". | nse |